Emerging use of nanoparticles in diagnosis and treatment of breast cancer.
暂无分享,去创建一个
Shuming Nie | Xiaohu Gao | S. Nie | Xiaohu Gao | R. O'Regan | M. Yezhelyev | Yun Xing | Ruth M O'Regan | Yun Xing | Maksym V Yezhelyev | Ahmad Al-Hajj | A. Al-Hajj | Maksym V. Yezhelyev
[1] R Weissleder,et al. Superparamagnetic iron oxide: enhanced detection of focal splenic tumors with MR imaging. , 1988, Radiology.
[2] S. Biesterfeld,et al. Analysis of the reliability of manual and automated immunohistochemical staining procedures. A pilot study. , 2003, Analytical and quantitative cytology and histology.
[3] J. Matthew Mauro,et al. Long-term multiple color imaging of live cells using quantum dot bioconjugates , 2003, Nature Biotechnology.
[4] Ulrich Beyer,et al. Liposomal encapsulated anti-cancer drugs. , 2005, Anti-cancer drugs.
[5] M. Hung,et al. Repressed expression of the HER-2/c-erbB-2 proto-oncogene by the adenovirus E1a gene products. , 1991, Oncogene.
[6] Brian Samuels,et al. Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] D. Tripathy,et al. Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. , 2004, The oncologist.
[8] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[9] J. Post,et al. Quantum dot ligands provide new insights into erbB/HER receptor–mediated signal transduction , 2004, Nature Biotechnology.
[10] K K Jain,et al. Personalised medicine for cancer: from drug development into clinical practice , 2005, Expert opinion on pharmacotherapy.
[11] Thomas J Deerinck,et al. Correlated light and electron microscopic imaging of multiple endogenous proteins using Quantum dots , 2005, Nature Methods.
[12] T. Fleming,et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. , 2001, The New England journal of medicine.
[13] Greg Yothers,et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. , 2005, The New England journal of medicine.
[14] Michael Hawkins,et al. Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol) , 2005, Clinical Cancer Research.
[15] Larry J Kricka,et al. Nanobiotechnology: the promise and reality of new approaches to molecular recognition. , 2005, Trends in biotechnology.
[16] J Verweij,et al. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. , 2001, European journal of cancer.
[17] Dmitri Artemov,et al. MR molecular imaging of the Her‐2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles , 2003, Magnetic resonance in medicine.
[18] Peter E Barker,et al. Semiconductor nanocrystal probes for human metaphase chromosomes. , 2004, Nucleic acids research.
[19] Ralph Weissleder,et al. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. , 2003, Cancer research.
[20] B. Seliger,et al. Small interfering RNA (siRNA) inhibits the expression of the Her2/neu gene, upregulates HLA class I and induces apoptosis of Her2/neu positive tumor cell lines , 2004, International journal of cancer.
[21] M. Amiji,et al. Poly(ethylene oxide)-modified poly(epsilon-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. , 2005, International journal of pharmaceutics.
[22] M. Bruchez,et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots , 2003, Nature Biotechnology.
[23] Erkki Ruoslahti,et al. Nanocrystal targeting in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[24] S. Nie,et al. In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.
[25] Y. Sugimoto,et al. Gene therapy for breast cancer. — review of clinical gene therapy trials for breast cancer and mdr1 gene therapy trial in cancer institute hospital , 2006, Breast cancer.
[26] Gottfried Konecny,et al. Quantitative association between HER-2/neu and steroid hormone receptors in hormone receptor-positive primary breast cancer. , 2003, Journal of the National Cancer Institute.
[27] Francis C Szoka,et al. Designing dendrimers for biological applications , 2005, Nature Biotechnology.
[28] B. Leyland-Jones,et al. Hypersensitivity reactions from taxol. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] M. Amiji,et al. Poly(ethylene oxide)-modified poly(ɛ-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer , 2005 .
[30] F. Marshall,et al. In vivo molecular and cellular imaging with quantum dots. , 2005, Current opinion in biotechnology.
[31] Hedi Mattoussi,et al. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy , 2004, Nature Medicine.
[32] Hiroyuki Honda,et al. Medical application of functionalized magnetic nanoparticles. , 2005, Journal of bioscience and bioengineering.
[33] Jan Grimm,et al. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles , 2006, Nature materials.
[34] S. Nie,et al. Simultaneous, quantitative detection of multiple biomarkers in breast cancers using semiconductor multicolor quantum dots , 2006 .
[35] C. Hélène,et al. Antisense oligonucleotides adsorbed to polyalkylcyanoacrylate nanoparticles specifically inhibit mutated Ha-ras-mediated cell proliferation and tumorigenicity in nude mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[36] Ming Zhao,et al. Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent , 2001, Nature Medicine.
[37] Michael Hawkins,et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] S. Martino,et al. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand‐binding assay compared with ER, PgR and pS2, by immuno‐histochemistry in predicting response to tamoxifen in metastatic breast cancer: A Southwest Oncology Group study , 2000, International journal of cancer.
[39] Semiconductor nanocrystal conjugates, FISH and pH , 2005, Nature Methods.
[40] Catherine Legrand. 1687Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials : Early Breast Cancer Trialists' Collaborative Group (EBCTCG) , 2005 .
[41] R. Stafford,et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[42] Donald A Tomalia,et al. Dendrimers in biomedical applications--reflections on the field. , 2005, Advanced drug delivery reviews.
[43] V. Labhasetwar,et al. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells. , 2004, Molecular pharmaceutics.
[44] M. Prato,et al. Chemistry of carbon nanotubes. , 2006, Chemical reviews.
[45] M. El-Tamer,et al. Allergic Reactions to Isosulfan Blue in Sentinel Lymph Node Mapping , 2005, The breast journal.
[46] Ron C. Hardman. A Toxicologic Review of Quantum Dots: Toxicity Depends on Physicochemical and Environmental Factors , 2005, Environmental health perspectives.
[47] G. Batist,et al. Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] S. Nie,et al. Quantum-dot-tagged microbeads for multiplexed optical coding of biomolecules , 2001, Nature Biotechnology.
[49] John W. Park. Liposome-based drug delivery in breast cancer treatment , 2002, Breast Cancer Research.
[50] J. Jaiswal,et al. Potentials and pitfalls of fluorescent quantum dots for biological imaging. , 2004, Trends in cell biology.
[51] A. Aigner,et al. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo , 2005, Gene Therapy.
[52] A. Darzi,et al. Diagnostic precision of nanoparticle-enhanced MRI for lymph-node metastases: a meta-analysis. , 2006, The Lancet. Oncology.
[53] C. Benz,et al. Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery , 2006, Gene Therapy.
[54] K. Jain,et al. Nanotechnology in clinical laboratory diagnostics. , 2005, Clinica chimica acta; international journal of clinical chemistry.
[55] Garry P. Nolan,et al. Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry , 2002, Nature Biotechnology.
[56] J. Menéndez,et al. Pharmacological and small interference RNA‐mediated inhibition of breast cancer‐associated fatty acid synthase (oncogenic antigen‐519) synergistically enhances Taxol (paclitaxel)‐induced cytotoxicity , 2005, International journal of cancer.
[57] T. Mihaljevic,et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping , 2004, Nature Biotechnology.
[58] Shuming Nie,et al. Spectroscopic tags using dye-embedded nanoparticles and surface-enhanced Raman scattering. , 2003, Analytical chemistry.
[59] Duncan Graham,et al. Rapid and ultra-sensitive determination of enzyme activities using surface-enhanced resonance Raman scattering , 2004, Nature Biotechnology.
[60] M. Ferrari. Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.
[61] Vladimir P Torchilin,et al. Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo , 2005, Nature Medicine.
[62] W. Smith,et al. Assessment of silver and gold substrates for the detection of amphetamine sulfate by surface enhanced Raman scattering (SERS). , 2002, The Analyst.
[63] Igor L. Medintz,et al. Quantum dot bioconjugates for imaging, labelling and sensing , 2005, Nature materials.
[64] R. Duncan. The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.
[65] Tony Yuen,et al. Method for multiplex cellular detection of mRNAs using quantum dot fluorescent in situ hybridization , 2005, Nucleic acids research.
[66] A. Santoro,et al. Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[67] Lyndsay N Harris,et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[68] H. Cody,et al. Clinical aspects of sentinel node biopsy , 2001, Breast Cancer Research.
[69] M. Prato,et al. Applications of carbon nanotubes in drug delivery. , 2005, Current opinion in chemical biology.
[70] G. Hortobagyi,et al. Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.